Effective December 04, 2018, Mr. Talari has resigned as the Acting CEO and director of Apotheca Biosciences, Inc. The decision was based on personal matters not related to any disagreement with the company. Effective December 04, 2018, Dr. P.C. Sundareswaran has been elected by the majority shareholders and the board of directors as the Chairman & CEO of Apotheca Biosciences. Mr. John Verghese, Company's CTO, will assume the acting CEO position until such time that Dr. P.C. Sundareswaran begins his position on Jan.

1 2019. Effective December 04, 2018, Mrs. Deidre Fernandes has been elected by the majority shareholders and the board of directors, as a director of the Company until the fiscal year 2019. Currently, Mrs. Fernandes holds the position of the COO of Apotheca.